Teaching cells to respond to physical forces
Programming cellular behavior by mechanical forces
Researchers are building tiny, programmable 'mechaswitches' that let cells like immune cells turn on when they feel specific mechanical forces, aiming to help people with cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11189698 on NIH RePORTER |
What this research studies
This project will create engineered protein and RNA devices called mechaswitches that detect mechanical forces inside and outside cells and trigger specific cellular responses. Scientists will combine protein design, RNA synthetic biology, and cell engineering to build and test these devices in lab-grown cells and immune cells relevant to cancer. The team will study whether mechaswitches can control T cell activation and other behaviors that matter for anti-tumor responses. These are preclinical laboratory experiments intended to enable future therapies rather than offering immediate treatments.
Who could benefit from this research
Good fit: People with cancers who are considering or eligible for cell-based immunotherapy trials, or who are willing to donate blood or tumor samples for lab research, would be most relevant to future participation.
Not a fit: Patients with conditions unrelated to cancer or those looking for immediate clinical treatment are unlikely to receive direct benefit from this basic science work right now.
Why it matters
Potential benefit: If successful, this could allow doctors to program immune or therapeutic cells to activate only under the right physical conditions, potentially improving how well they target tumors and reducing side effects.
How similar studies have performed: Prior laboratory studies show mechanical forces can change immune and stem cell behavior, but building programmable intracellular mechanical sensors is a novel approach with limited prior clinical testing.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Berro, Julien — Yale University
- Study coordinator: Berro, Julien
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.